Insulin Delivery Devices Market - Global Trends, and Forecast to 2025
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin infusion(CSII) using an insulin pump and insulin therapy using multiple daily injections (MDI) to more closely match physiologic insulin patterns. Type or dosage of insulin can be changed, to meet the individual needs of the patient. Insulin can be packaged in vials (bottles), cartridges or prefilled pens. The cartridges are used with pen injectors whereas the vials are used with syringes.
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin infusion(CSII) using an insulin pump and insulin therapy using multiple daily injections (MDI) to more closely match physiologic insulin patterns. Type or dosage of insulin can be changed, to meet the individual needs of the patient. Insulin can be packaged in vials (bottles), cartridges or prefilled pens. The cartridges are used with pen injectors whereas the vials are used with syringes.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REPORT DESCRIPTION<br />
<strong>Insulin</strong> <strong>Delivery</strong> <strong>Devices</strong> <strong>Market</strong> – Overview<br />
<strong>Insulin</strong> is vital for people suffering from type 1 diabetes <strong>and</strong> type 2 diabetes. In the past, patients with diabetes had <strong>to</strong> inject<br />
insulin using large glass syringes <strong>and</strong> reusable needles, both of which needed sterilization by boiling after each use.<br />
Improvements <strong>and</strong> innovations has led <strong>to</strong> development of insulin delivery devices such as pens <strong>and</strong> insulin pumps.<br />
Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin infusion(CSII) using<br />
an insulin pump <strong>and</strong> insulin therapy using multiple daily injections (MDI) <strong>to</strong> more closely match physiologic insulin<br />
patterns. Type or dosage of insulin can be changed, <strong>to</strong> meet the individual needs of the patient. <strong>Insulin</strong> can be packaged in<br />
vials (bottles), cartridges or prefilled pens. The cartridges are used with pen injec<strong>to</strong>rs whereas the vials are used with<br />
syringes.<br />
The global insulin delivery devices market was valued at US$ 11,326.9 million in 2017 <strong>and</strong> is expected <strong>to</strong> witness a CAGR of<br />
11.3% over the forecast period (2017–<strong>2025</strong>).<br />
Increasing prevalence <strong>and</strong> incidence of diabetes is a major fac<strong>to</strong>r driving the insulin delivery devices market growth. According <strong>to</strong><br />
the Centers for Disease Control <strong>and</strong> Prevention (CDC), 2014, about 29.1 million people in the U.S. have diabetes with a healthcare<br />
burden of around US$ 245 Bn <strong>and</strong> with an estimated 4.6–9.2% of pregnant women affected by gestational diabetes. Moreover, the<br />
Australian government launched National Diabetes Strategy (2016–20), for an action <strong>to</strong> prevent diabetes <strong>and</strong> support the people<br />
living with diabetes. Thus, rise in government initiatives <strong>to</strong> support diabetic patients is expected <strong>to</strong> favor growth of the insulin<br />
delivery devices market.<br />
© Coherent market Insights. All Rights Reserved
Change language